Sign In
Buy PPCB
$1.60
-0.0100 (-0.621%)
At Close: Jul 13, 2026
Propanc Biopharma to Present at the 2019 BIO CEO & Investor Conference
09:00am, Tuesday, 29'th Jan 2019
MELBOURNE, Australia--(BUSINESS WIRE)--Propanc Biopharma, Inc. (OTCQB: PPCB) (“Propanc”), a clinical stage biopharmaceutical company focused on development of new and proprietary treatments for ca
